N-Terminal Hypothesis for Alzheimer's Disease

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• The amyloid hypothesis, a leading theory in Alzheimer's disease (AD) pathogenesis for 25 years, faces ongoing controversy.
• A mechanistic link between amyloid precursor protein (APP) cleavage products and synaptic dysfunction in AD is not fully established.

Purpose of the Study:

• To investigate the role of amyloid-beta (Aβ) oligomers in Alzheimer's disease (AD) pathogenesis.
• To elucidate the specific Aβ species and their structural domains responsible for synaptic dysfunction.

Main Methods:

• Review of recent literature on Aβ aggregation, clearance, and structural morphology.
• Analysis of molecular simulations and long-term potentiation (LTP) measurements.
• Investigation of aducanumab binding to Aβ species.

Main Results:

• Evidence suggests a gap in understanding the mechanistic pathway from soluble Aβ to synaptic damage.
• The N-terminal domains of neurotoxic Aβ oligomers are implicated as a potential cause of AD.
• Aβ oligomer structure and clearance mechanisms are critical factors in AD pathology.

Conclusions:

• The N-terminal domains of specific amyloid-beta (Aβ) oligomers are hypothesized to be crucial in Alzheimer's disease (AD) pathogenesis.
• Further research into Aβ oligomer structure and function is essential for developing effective AD treatments.
• Understanding these mechanisms could refine the amyloid hypothesis and guide therapeutic strategies.